Clinical Trials Directory

Trials / Completed

CompletedNCT00018564

Novel Therapies for Essential Tremor

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
Sponsor
US Department of Veterans Affairs · Federal
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This clinical research program is designed to evaluate medications as new treatments for essential tremor. Essential tremor is a common condition with few available therapies.

Detailed description

Each medication will be evaluated for effectiveness against tremor in a randomized, placebo-controlled, cross-over, double blind clinical research trial. Tremor will be assessed with accepted rating scales and accelerometry

Conditions

Interventions

TypeNameDescription
DRUGtreatments for essential tremor

Timeline

Start date
2000-10-01
Completion
2003-09-01
First posted
2001-07-05
Last updated
2009-01-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00018564. Inclusion in this directory is not an endorsement.

Novel Therapies for Essential Tremor (NCT00018564) · Clinical Trials Directory